Selank - Research Grade

Selank

Informative Description:  Selank is a synthetic heptapeptide developed by merging the sequence of the endogenous tetrapeptide Tuftsin with a three-amino-acid stabilizer at its C-terminus. This distinct structural modification grants it significantly prolonged metabolic stability within blood plasma, allowing it to act directly within the central nervous system as a potent anxiolytic and nootropic agent without inducing sedative effects or dependence.
Peptide Function:
 GABAergic System Modulation: Optimizes gamma-aminobutyric acid (GABA) neurotransmission by enhancing receptor affinity, physiological promoting a state of calm and anxiety reduction.
 Enkephalin Regulation & BDNF Expression: Inhibits the enzymes responsible for degrading enkephalins (endogenous opioid peptides that regulate stress responses) and upregulates Brain-Derived Neurotrophic Factor (BDNF) levels in the hippocampus.
 Immunomodulatory Influence: Derived from Tuftsin, it retains the ability to modulate interleukin expression (such as IL-6) and the adaptive immune system's response to acute or chronic psychophysical stress.
Primary Uses (Research Applications):
 Anxiety & Stress Regulation Studies: Extensively researched in neuroscience as a model for treating generalized anxiety disorder (GAD), evaluating its capacity to mitigate stress without causing lethargy, motor impairment, or drowsiness.
 Cognitive Enhancement & Memory Research: Utilized in laboratory protocols to analyze increases in synaptic plasticity, working memory consolidation, and attentional performance under psychological pressure.
 Neuroprotection & Mood Stabilization Models: Evaluated in scientific studies for its potential to restore neurotransmitter equilibrium following periods of nervous exhaustion, as well as its protective role against neuronal oxidative damage.

IMPORTANT NOTICE
FOR RESEARCH USE ONLY.
NOT FOR HUMAN OR VETERINARY CONSUMPTION.

This product is not intended to diagnose, treat, cure, or prevent any disease.